Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PTLA | Portola Pharmaceuticals, Inc. | -0.50% | 17.86 | 6.5% | $171.15m | |
| HZNP | Horizon Therapeutics Plc | -1.66% | 49.89 | 6.5% | $147.25m | |
| CTLT | Catalent, Inc. | -1.40% | 76.64 | 2.3% | $136.90m | |
| MYOK | MyoKardia, Inc. | 0.71% | 103.02 | 1.8% | $136.53m | |
| BHC | Bausch Health Cos., Inc. | 3.68% | 19.16 | 0.0% | $128.68m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 3.68% | 19.16 | 14.1% | $112.74m | |
| UTHR | United Therapeutics Corp. | 1.98% | 120.28 | 14.3% | $72.90m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.77% | 73.54 | 16.8% | $62.73m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.04% | 119.37 | 2.4% | $59.79m | |
| ARGX | argenx SE | 2.79% | 225.41 | 0.0% | $57.13m | |
| GWPH | GW Pharmaceuticals Plc | 1.65% | 124.78 | 6.2% | $55.16m | |
| AMRN | Amarin Corp. Plc | -2.19% | 6.71 | 1.6% | $53.25m | |
| AXSM | Axsome Therapeutics, Inc. | 0.01% | 76.99 | 1.9% | $49.15m | |
| PRGO | Perrigo Co. Plc | 1.21% | 55.43 | 6.8% | $42.75m | |
| ICLR | ICON plc | 0.77% | 169.74 | 4.3% | $42.50m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.